Benaim Ely
SEC CIK 1632237 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Chief Medical Off | 28.8K | — | $1.15M | 12 | 2021-07-06 | 2023-01-06 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
Benaim Ely made no open-market trades at NVCR in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-10 | 2023-01-06 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | A - Grant | $62.31 | +98 | 28.8K | +0.3% | +$6,106 | |
| M | 2022-08-04 | 2022-08-03 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | S - Sale | $73.73 | -5,959 | 28.7K | -17% | -$439.3K |
| 2022-08-03 | 2022-08-02 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | S - Sale | $69.66 | -437 | 34.6K | -1% | -$30.4K | |
| 2022-07-07 | 2022-07-05 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | A - Grant | $59.08 | +222 | 35.1K | +0.6% | +$13.1K | |
| M | 2022-05-12 | 2022-05-10+ | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | S - Sale | $63.17 | -4,205 | 34.8K | -11% | -$265.6K |
| DM | 2022-03-07 | 2022-03-03+ | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | S - Sale | $71.83 | -2,313 | 44.8K | -5% | -$166.1K |
| D | 2022-03-07 | 2022-03-03 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | A - Grant | $0.00 | +17.4K | 45.6K | +62% | $0 |
| 2022-01-12 | 2022-01-06 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | A - Grant | $63.82 | +55 | 28.2K | +0.2% | +$3,510 | |
| 2021-08-04 | 2021-08-03 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | S - Sale | $150.11 | -464 | 28.1K | -2% | -$69.7K | |
| D | 2021-08-03 | 2021-07-30 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | M - OptEx | $83.30 | +651 | 29.8K | +2% | +$54.2K |
| DM | 2021-08-03 | 2021-07-30+ | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | S - Sale+OE | $154.63 | -1,187 | 28.6K | -4% | -$183.6K |
| 2021-07-08 | 2021-07-06 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Off | A - Grant | $137.12 | +90 | 29.1K | +0.3% | +$12.3K |
Purchase Sale Sale after option exercise All abbreviations